These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1988705)

  • 1. Diffusion and binding of monoclonal antibody TNT-1 in multicellular tumor spheroids.
    Cheng FM; Hansen EB; Taylor CR; Epstein AL
    J Natl Cancer Inst; 1991 Feb; 83(3):200-4. PubMed ID: 1988705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake kinetics of monoclonal antibodies by human malignant melanoma multicell spheroids.
    Kwok CS; Cole SE; Liao SK
    Cancer Res; 1988 Apr; 48(7):1856-63. PubMed ID: 3349464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical model of simultaneous diffusion and binding of antitumor antibodies in multicellular human tumor spheroids.
    McFadden R; Kwok CS
    Cancer Res; 1988 Jul; 48(14):4032-7. PubMed ID: 3383196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 131I-labeled TNT-1 radioimmunotherapy on HT-29 human colon adenocarcinoma spheroids.
    Chen FM; Liu CZ; Epstein AL
    Cancer Immunol Immunother; 1991; 33(3):158-64. PubMed ID: 2044081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.
    Sutherland R; Buchegger F; Schreyer M; Vacca A; Mach JP
    Cancer Res; 1987 Mar; 47(6):1627-33. PubMed ID: 3545451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons between two monoclonal antibodies that bind to the same antigen but have differing affinities: uptake kinetics and 125I-antibody therapy efficacy in multicell spheroids.
    Langmuir VK; Mendonca HL; Woo DV
    Cancer Res; 1992 Sep; 52(17):4728-34. PubMed ID: 1511438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homogeneous penetration but heterogeneous binding of antibodies to carcinoembryonic antigen in human colon carcinoma HT-29 spheroids.
    Carlsson J; Daniel-Szolgay E; Frykholm G; Glimelius B; Hedin A; Larsson B
    Cancer Immunol Immunother; 1989; 30(5):269-76. PubMed ID: 2624920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of seven new vasoactive immunoconjugates on the enhancement of monoclonal antibody uptake in tumors.
    Khawli LA; Miller GK; Epstein AL
    Cancer; 1994 Feb; 73(3 Suppl):824-31. PubMed ID: 8306266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cell spheroids as a model for evaluation of metabolic changes after irradiation.
    Senekowitsch-Schmidtke R; Matzen K; Truckenbrodt R; Mattes J; Heiss P; Schwaiger M
    J Nucl Med; 1998 Oct; 39(10):1762-8. PubMed ID: 9776284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygenation and differentiation in multicellular spheroids of human colon carcinoma.
    Sutherland RM; Sordat B; Bamat J; Gabbert H; Bourrat B; Mueller-Klieser W
    Cancer Res; 1986 Oct; 46(10):5320-9. PubMed ID: 3756881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a phage display-derived human monoclonal antibody (NHS76) counterpart to chimeric TNT-1 directed against necrotic regions of solid tumors.
    Sharifi J; Khawli LA; Hu P; King S; Epstein AL
    Hybrid Hybridomics; 2001; 20(5-6):305-12. PubMed ID: 11839248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose diffusivity in multicellular tumor spheroids.
    Casciari JJ; Sotirchos SV; Sutherland RM
    Cancer Res; 1988 Jul; 48(14):3905-9. PubMed ID: 3383189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric TNT-3/human beta-glucuronidase fusion proteins for antibody-directed enzyme prodrug therapy (ADEPT).
    Biela BH; Khawli LA; Hu P; Epstein AL
    Cancer Biother Radiopharm; 2003 Jun; 18(3):339-53. PubMed ID: 12954121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of monoclonal antibody TNT-1 in experimental kidney infarction of the mouse.
    Chen FM; Wisner JR; Omachi H; Renner IG; Taylor CR; Epstein AL
    FASEB J; 1990 Sep; 4(12):3033-9. PubMed ID: 2394321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new chemically modified chimeric TNT-3 monoclonal antibody directed against DNA for the radioimmunotherapy of solid tumors.
    Hornick JL; Sharifi J; Khawli LA; Hu P; Biela BH; Mizokami MM; Yun A; Taylor CR; Epstein AL
    Cancer Biother Radiopharm; 1998 Aug; 13(4):255-68. PubMed ID: 10850361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional and systemic distribution of anti-tumor x anti-CD3 heteroaggregate antibodies and cultured human peripheral blood lymphocytes in a human colon cancer xenograft.
    Nelson H; Ramsey PS; Kerr LA; McKean DJ; Donohue JH
    J Immunol; 1990 Nov; 145(10):3507-15. PubMed ID: 1700013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of radioimmunotherapy using human malignant melanoma multicell spheroids as a model.
    Kwok CS; Crivici A; MacGregor WD; Unger MW
    Cancer Res; 1989 Jun; 49(12):3276-81. PubMed ID: 2720681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative targeting of human colon-carcinoma multicell spheroids using one- and two-step (bispecific antibody) techniques.
    Devys A; Thedrez P; Gautherot E; Faivre-Chauvet A; Saï-Maurel C; Rouvier E; Auget JL; Barbet J; Chatal JF
    Int J Cancer; 1996 Sep; 67(6):883-91. PubMed ID: 8824563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake, penetration, and binding of monoclonal antibodies with increasing affinity in human osteosarcoma multicell spheroids.
    Hjelstuen MH; Rasch-Halvorsen K; Bruland O; De L Davies C
    Anticancer Res; 1998; 18(5A):3153-61. PubMed ID: 9858878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth of prostatic cancer cells, DU 145, as multicellular spheroids and effects of estramustine.
    Essand M; Nilsson S; Carlsson J
    Anticancer Res; 1993; 13(5A):1261-8. PubMed ID: 8239495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.